These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 12440855)
1. Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with alpha-cyclodextrin. Kihara F; Arima H; Tsutsumi T; Hirayama F; Uekama K Bioconjug Chem; 2002; 13(6):1211-9. PubMed ID: 12440855 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo gene transfer by an optimized alpha-cyclodextrin conjugate with polyamidoamine dendrimer. Kihara F; Arima H; Tsutsumi T; Hirayama F; Uekama K Bioconjug Chem; 2003; 14(2):342-50. PubMed ID: 12643744 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of gene expression by polyamidoamine dendrimer conjugates with alpha-, beta-, and gamma-cyclodextrins. Arima H; Kihara F; Hirayama F; Uekama K Bioconjug Chem; 2001; 12(4):476-84. PubMed ID: 11459450 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of gene transfer activity mediated by mannosylated dendrimer/alpha-cyclodextrin conjugate (generation 3, G3). Arima H; Chihara Y; Arizono M; Yamashita S; Wada K; Hirayama F; Uekama K J Control Release; 2006 Nov; 116(1):64-74. PubMed ID: 17083992 [TBL] [Abstract][Full Text] [Related]
5. Enhancing effects of galactosylated dendrimer/alpha-cyclodextrin conjugates on gene transfer efficiency. Wada K; Arima H; Tsutsumi T; Hirayama F; Uekama K Biol Pharm Bull; 2005 Mar; 28(3):500-5. PubMed ID: 15744077 [TBL] [Abstract][Full Text] [Related]
6. Sugar-appended polyamidoamine dendrimer conjugates with cyclodextrins as cell-specific non-viral vectors. Arima H; Motoyama K; Higashi T Adv Drug Deliv Rev; 2013 Aug; 65(9):1204-14. PubMed ID: 23602906 [TBL] [Abstract][Full Text] [Related]
7. [Polyfection as nonviral gene transfer method -design of novel nonviral vector using alpha-cyclodextrin]. Arima H Yakugaku Zasshi; 2004 Jul; 124(7):451-64. PubMed ID: 15235229 [TBL] [Abstract][Full Text] [Related]
8. Possible enhancing mechanisms for gene transfer activity of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate. Anno T; Higashi T; Motoyama K; Hirayama F; Uekama K; Arima H Int J Pharm; 2012 Apr; 426(1-2):239-247. PubMed ID: 22306427 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA). Tsutsumi T; Hirayama F; Uekama K; Arima H J Control Release; 2007 Jun; 119(3):349-59. PubMed ID: 17477999 [TBL] [Abstract][Full Text] [Related]
10. Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cells. Arima H; Arizono M; Higashi T; Yoshimatsu A; Ikeda H; Motoyama K; Hattori K; Takeuchi T; Hirayama F; Uekama K Cancer Gene Ther; 2012 May; 19(5):358-66. PubMed ID: 22402627 [TBL] [Abstract][Full Text] [Related]
11. Improvement of gene delivery mediated by mannosylated dendrimer/alpha-cyclodextrin conjugates. Wada K; Arima H; Tsutsumi T; Chihara Y; Hattori K; Hirayama F; Uekama K J Control Release; 2005 May; 104(2):397-413. PubMed ID: 15907588 [TBL] [Abstract][Full Text] [Related]
12. Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a DNA carrier in vitro and in vivo. Anno T; Higashi T; Motoyama K; Hirayama F; Uekama K; Arima H J Drug Target; 2012 Apr; 20(3):272-80. PubMed ID: 22201459 [TBL] [Abstract][Full Text] [Related]
14. Effects of dendrimer/cyclodextrin conjugates as gene transfer carriers on nitric oxide production from macrophages. Motoyama K; Sako A; Ibrahim Abu Hashim I; Higashi T; Arima H J Pharm Pharmacol; 2016 May; 68(5):598-607. PubMed ID: 26076676 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/alpha-cyclodextrin conjugates (G2) into hepatocytes. Arima H; Yamashita S; Mori Y; Hayashi Y; Motoyama K; Hattori K; Takeuchi T; Jono H; Ando Y; Hirayama F; Uekama K J Control Release; 2010 Aug; 146(1):106-17. PubMed ID: 20678990 [TBL] [Abstract][Full Text] [Related]
16. Polypseudorotaxanes of pegylated α-cyclodextrin/polyamidoamine dendrimer conjugate with cyclodextrins as a sustained release system for DNA. Motoyama K; Hayashida K; Higashi T; Arima H Bioorg Med Chem; 2012 Feb; 20(4):1425-33. PubMed ID: 22277591 [TBL] [Abstract][Full Text] [Related]
17. Potential use of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for short hairpin RNA-expressing plasmid DNA. Tsutsumi T; Hirayama F; Uekama K; Arima H J Pharm Sci; 2008 Aug; 97(8):3022-34. PubMed ID: 17932986 [TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of polyamidoamine dendrimer conjugate with PEG, α-cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in vivo. Hayashi Y; Higashi T; Motoyama K; Mori Y; Jono H; Ando Y; Arima H J Drug Target; 2013 May; 21(5):487-96. PubMed ID: 23570609 [TBL] [Abstract][Full Text] [Related]
19. Potential Use of Thioalkylated Mannose-Modified Dendrimer (G3)/α-Cyclodextrin Conjugate as an NF-κB siRNA Carrier for the Treatment of Fulminant Hepatitis. Motoyama K; Mitsuyasu R; Akao C; Abu Hashim II; Sato N; Tanaka T; Higashi T; Arima H Mol Pharm; 2015 Sep; 12(9):3129-36. PubMed ID: 26270769 [TBL] [Abstract][Full Text] [Related]
20. Cyclodextrin/Dendrimer conjugates as DNA and oligonucleotide carriers. Arima H; Motoyama K; Higashi T Curr Top Med Chem; 2014; 14(4):465-77. PubMed ID: 24354672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]